Annual Net Income
$2.12 B
-$29.25 B-93.25%
31 December 2023
Summary:
Pfizer annual net profit is currently $2.12 billion, with the most recent change of -$29.25 billion (-93.25%) on 31 December 2023. During the last 3 years, it has fallen by -$7.04 billion (-76.86%). PFE annual net income is now -93.25% below its all-time high of $31.37 billion, reached on 31 December 2022.PFE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$4.46 B
+$4.42 B+10790.24%
30 September 2024
Summary:
Pfizer quarterly net profit is currently $4.46 billion, with the most recent change of +$4.42 billion (+10790.24%) on 30 September 2024. Over the past year, it has increased by +$6.85 billion (+287.45%). PFE quarterly net income is now -68.32% below its all-time high of $14.10 billion, reached on 30 June 2013.PFE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$4.25 B
+$6.85 B+263.85%
30 September 2024
Summary:
Pfizer TTM net profit is currently $4.25 billion, with the most recent change of +$6.85 billion (+263.85%) on 30 September 2024. Over the past year, it has dropped by -$6.23 billion (-59.44%). PFE TTM net income is now -86.45% below its all-time high of $31.37 billion, reached on 31 December 2022.PFE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.3% | +287.4% | -59.4% |
| 3 y3 years | -76.9% | -45.2% | -78.1% |
| 5 y5 years | -81.0% | -41.9% | -73.8% |
PFE Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -93.3% | at low | -54.9% | +232.5% | -86.5% | +263.9% |
| 5 y | 5 years | -93.3% | at low | -54.9% | +232.5% | -86.5% | +263.9% |
| alltime | all time | -93.3% | +317.2% | -68.3% | +224.3% | -86.5% | +263.9% |
Pfizer Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.46 B(>+9900.0%) | $4.25 B(-263.9%) |
| June 2024 | - | $41.00 M(-98.7%) | -$2.60 B(+739.8%) |
| Mar 2024 | - | $3.12 B(-192.5%) | -$309.00 M(-114.6%) |
| Dec 2023 | $2.12 B(-93.2%) | -$3.37 B(+41.4%) | $2.12 B(-79.8%) |
| Sept 2023 | - | -$2.38 B(-202.4%) | $10.48 B(-51.2%) |
| June 2023 | - | $2.33 B(-58.0%) | $21.47 B(-26.1%) |
| Mar 2023 | - | $5.54 B(+11.0%) | $29.05 B(-7.4%) |
| Dec 2022 | $31.37 B(+42.7%) | $4.99 B(-42.0%) | $31.37 B(+5.4%) |
| Sept 2022 | - | $8.61 B(-13.1%) | $29.77 B(+1.6%) |
| June 2022 | - | $9.91 B(+26.0%) | $29.31 B(+17.4%) |
| Mar 2022 | - | $7.86 B(+131.8%) | $24.97 B(+13.6%) |
| Dec 2021 | $21.98 B(+140.0%) | $3.39 B(-58.3%) | $21.98 B(+13.1%) |
| Sept 2021 | - | $8.15 B(+46.4%) | $19.43 B(+52.3%) |
| June 2021 | - | $5.56 B(+14.1%) | $12.76 B(+19.4%) |
| Mar 2021 | - | $4.88 B(+476.5%) | $10.68 B(+16.6%) |
| Dec 2020 | $9.16 B(-42.8%) | $846.00 M(-42.4%) | $9.16 B(+18.5%) |
| Sept 2020 | - | $1.47 B(-57.9%) | $7.73 B(-44.6%) |
| June 2020 | - | $3.49 B(+4.0%) | $13.94 B(-10.0%) |
| Mar 2020 | - | $3.35 B(-675.5%) | $15.50 B(-3.3%) |
| Dec 2019 | $16.03 B(+43.7%) | -$583.00 M(-107.6%) | $16.03 B(-1.2%) |
| Sept 2019 | - | $7.68 B(+52.2%) | $16.22 B(+28.2%) |
| June 2019 | - | $5.05 B(+29.9%) | $12.65 B(+10.2%) |
| Mar 2019 | - | $3.88 B(-1088.3%) | $11.48 B(+2.9%) |
| Dec 2018 | $11.15 B(-47.7%) | -$393.00 M(-109.6%) | $11.15 B(-53.2%) |
| Sept 2018 | - | $4.11 B(+6.3%) | $23.82 B(+5.7%) |
| June 2018 | - | $3.87 B(+8.7%) | $22.55 B(+3.7%) |
| Mar 2018 | - | $3.56 B(-71.0%) | $21.75 B(+2.1%) |
| Dec 2017 | $21.31 B(+195.3%) | $12.27 B(+332.2%) | $21.31 B(+117.2%) |
| Sept 2017 | - | $2.84 B(-7.6%) | $9.81 B(+17.8%) |
| June 2017 | - | $3.07 B(-1.5%) | $8.32 B(+14.1%) |
| Mar 2017 | - | $3.12 B(+302.7%) | $7.30 B(+1.2%) |
| Dec 2016 | $7.21 B(+3.7%) | $775.00 M(-42.8%) | $7.21 B(+15.1%) |
| Sept 2016 | - | $1.35 B(-33.8%) | $6.27 B(-11.0%) |
| June 2016 | - | $2.05 B(-32.6%) | $7.04 B(-7.6%) |
| Mar 2016 | - | $3.04 B(-1866.3%) | $7.62 B(+9.5%) |
| Dec 2015 | $6.96 B(-23.8%) | -$172.00 M(-108.1%) | $6.96 B(-16.7%) |
| Sept 2015 | - | $2.13 B(-18.9%) | $8.36 B(-6.0%) |
| June 2015 | - | $2.63 B(+10.5%) | $8.90 B(-3.1%) |
| Mar 2015 | - | $2.38 B(+93.5%) | $9.18 B(+0.5%) |
| Dec 2014 | $9.13 B(-58.5%) | $1.23 B(-53.9%) | $9.13 B(-12.8%) |
| Sept 2014 | - | $2.67 B(-8.4%) | $10.47 B(+0.7%) |
| June 2014 | - | $2.91 B(+25.0%) | $10.40 B(-51.8%) |
| Mar 2014 | - | $2.33 B(-9.3%) | $21.58 B(-1.9%) |
| Dec 2013 | $22.00 B(+51.0%) | $2.57 B(-0.8%) | $22.00 B(-14.6%) |
| Sept 2013 | - | $2.59 B(-81.6%) | $25.75 B(-2.3%) |
| June 2013 | - | $14.10 B(+412.5%) | $26.37 B(+69.8%) |
| Mar 2013 | - | $2.75 B(-56.5%) | $15.53 B(+6.6%) |
| Dec 2012 | $14.57 B(+45.6%) | $6.32 B(+96.9%) | $14.57 B(+50.3%) |
| Sept 2012 | - | $3.21 B(-1.4%) | $9.69 B(-5.2%) |
| June 2012 | - | $3.25 B(+81.3%) | $10.22 B(+6.7%) |
| Mar 2012 | - | $1.79 B(+24.7%) | $9.58 B(-4.3%) |
| Dec 2011 | $10.01 B(+21.2%) | $1.44 B(-61.5%) | $10.01 B(-12.7%) |
| Sept 2011 | - | $3.74 B(+43.2%) | $11.46 B(+33.4%) |
| June 2011 | - | $2.61 B(+17.5%) | $8.59 B(+1.6%) |
| Mar 2011 | - | $2.22 B(-23.1%) | $8.45 B(+2.4%) |
| Dec 2010 | $8.26 B(-4.4%) | $2.89 B(+233.7%) | $8.26 B(+34.6%) |
| Sept 2010 | - | $866.00 M(-65.0%) | $6.13 B(-24.7%) |
| June 2010 | - | $2.48 B(+22.2%) | $8.15 B(+2.7%) |
| Mar 2010 | - | $2.03 B(+164.1%) | $7.93 B(-8.1%) |
| Dec 2009 | $8.63 B(+6.6%) | $767.00 M(-73.3%) | $8.63 B(+6.2%) |
| Sept 2009 | - | $2.88 B(+27.3%) | $8.13 B(+8.0%) |
| June 2009 | - | $2.26 B(-17.1%) | $7.53 B(-6.4%) |
| Mar 2009 | - | $2.73 B(+925.9%) | $8.05 B(-0.7%) |
| Dec 2008 | $8.10 B(-0.5%) | $266.00 M(-88.3%) | $8.10 B(-23.3%) |
| Sept 2008 | - | $2.28 B(-17.9%) | $10.56 B(+16.8%) |
| June 2008 | - | $2.78 B(-0.3%) | $9.04 B(+20.0%) |
| Mar 2008 | - | $2.78 B(+2.2%) | $7.54 B(-7.5%) |
| Dec 2007 | $8.14 B(-57.9%) | $2.72 B(+258.0%) | $8.14 B(-45.2%) |
| Sept 2007 | - | $761.00 M(-39.9%) | $14.87 B(-14.9%) |
| June 2007 | - | $1.27 B(-62.6%) | $17.47 B(-6.2%) |
| Mar 2007 | - | $3.39 B(-64.1%) | $18.62 B(-3.7%) |
| Dec 2006 | $19.34 B(+139.2%) | $9.45 B(+181.1%) | $19.34 B(+53.2%) |
| Sept 2006 | - | $3.36 B(+39.2%) | $12.62 B(+16.3%) |
| June 2006 | - | $2.42 B(-41.3%) | $10.85 B(-8.8%) |
| Mar 2006 | - | $4.11 B(+50.4%) | $11.90 B(+47.1%) |
| Dec 2005 | $8.09 B(-28.8%) | $2.73 B(+72.0%) | $8.09 B(-1.1%) |
| Sept 2005 | - | $1.59 B(-54.1%) | $8.18 B(-17.6%) |
| June 2005 | - | $3.46 B(+1050.5%) | $9.93 B(+6.4%) |
| Mar 2005 | - | $301.00 M(-89.3%) | $9.33 B(-17.9%) |
| Dec 2004 | $11.36 B | $2.83 B(-15.4%) | $11.36 B(+24.3%) |
| Sept 2004 | - | $3.34 B(+16.7%) | $9.14 B(+13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $2.86 B(+22.8%) | $8.03 B(+409.3%) |
| Mar 2004 | - | $2.33 B(+287.2%) | $1.58 B(-59.7%) |
| Dec 2003 | $3.91 B(-57.2%) | $602.00 M(-73.1%) | $3.91 B(-36.6%) |
| Sept 2003 | - | $2.23 B(-162.2%) | $6.17 B(-1.8%) |
| June 2003 | - | -$3.59 B(-177.0%) | $6.28 B(-46.9%) |
| Mar 2003 | - | $4.67 B(+63.3%) | $11.83 B(+29.6%) |
| Dec 2002 | $9.13 B(+17.2%) | $2.86 B(+21.5%) | $9.13 B(+10.9%) |
| Sept 2002 | - | $2.35 B(+20.1%) | $8.23 B(+3.5%) |
| June 2002 | - | $1.96 B(-0.3%) | $7.95 B(+1.6%) |
| Mar 2002 | - | $1.96 B(+0.4%) | $7.82 B(+0.4%) |
| Dec 2001 | $7.79 B(+109.0%) | $1.96 B(-5.6%) | $7.79 B(+7.4%) |
| Sept 2001 | - | $2.07 B(+13.3%) | $7.25 B(+10.9%) |
| June 2001 | - | $1.83 B(-5.2%) | $6.54 B(+11.6%) |
| Mar 2001 | - | $1.93 B(+35.9%) | $5.86 B(+57.3%) |
| Dec 2000 | $3.73 B(-24.8%) | $1.42 B(+4.3%) | $3.73 B(-1.3%) |
| Sept 2000 | - | $1.36 B(+18.3%) | $3.78 B(+7.2%) |
| June 2000 | - | $1.15 B(-663.7%) | $3.52 B(-0.3%) |
| Mar 2000 | - | -$204.00 M(-113.9%) | $3.53 B(-22.4%) |
| Dec 1999 | $4.95 B(+6.9%) | $1.47 B(+32.6%) | $4.55 B(-8.9%) |
| Sept 1999 | - | $1.11 B(-4.6%) | $5.00 B(-5.5%) |
| June 1999 | - | $1.16 B(+42.5%) | $5.29 B(+11.2%) |
| Mar 1999 | - | $815.00 M(-57.5%) | $4.76 B(+2.7%) |
| Dec 1998 | $4.63 B(+109.4%) | $1.92 B(+37.2%) | $4.63 B(+41.5%) |
| Sept 1998 | - | $1.40 B(+122.5%) | $3.27 B(+32.4%) |
| June 1998 | - | $628.00 M(-9.2%) | $2.47 B(+7.4%) |
| Mar 1998 | - | $692.00 M(+24.0%) | $2.30 B(+4.1%) |
| Dec 1997 | $2.21 B(+14.7%) | $558.00 M(-6.4%) | $2.21 B(+2.5%) |
| Sept 1997 | - | $596.00 M(+30.4%) | $2.16 B(+3.9%) |
| June 1997 | - | $457.00 M(-24.1%) | $2.08 B(+3.1%) |
| Mar 1997 | - | $602.00 M(+19.4%) | $2.01 B(+4.4%) |
| Dec 1996 | $1.93 B(+22.6%) | $504.00 M(-1.9%) | $1.93 B(+5.1%) |
| Sept 1996 | - | $514.00 M(+30.5%) | $1.84 B(+5.1%) |
| June 1996 | - | $394.00 M(-23.8%) | $1.75 B(+4.7%) |
| Mar 1996 | - | $517.00 M(+25.8%) | $1.67 B(+6.1%) |
| Dec 1995 | $1.57 B(+21.1%) | $410.90 M(-3.4%) | $1.57 B(+5.1%) |
| Sept 1995 | - | $425.30 M(+34.5%) | $1.50 B(+6.3%) |
| June 1995 | - | $316.30 M(-24.8%) | $1.41 B(+4.4%) |
| Mar 1995 | - | $420.40 M(+25.9%) | $1.35 B(+3.8%) |
| Dec 1994 | $1.30 B(+97.5%) | $334.00 M(-0.7%) | $1.30 B(+3.6%) |
| Sept 1994 | - | $336.50 M(+30.8%) | $1.25 B(+78.4%) |
| June 1994 | - | $257.20 M(-30.6%) | $702.60 M(+0.5%) |
| Mar 1994 | - | $370.70 M(+28.3%) | $699.20 M(+6.3%) |
| Dec 1993 | $657.50 M(-18.9%) | $288.90 M(-234.9%) | $657.50 M(+71.6%) |
| Sept 1993 | - | -$214.20 M(-184.4%) | $383.10 M(-57.2%) |
| June 1993 | - | $253.80 M(-22.9%) | $894.80 M(+5.9%) |
| Mar 1993 | - | $329.00 M(+2169.0%) | $844.80 M(+4.2%) |
| Dec 1992 | $810.90 M(+12.3%) | $14.50 M(-95.1%) | $810.90 M(+1.7%) |
| Sept 1992 | - | $297.50 M(+46.0%) | $797.30 M(+2.9%) |
| June 1992 | - | $203.80 M(-30.9%) | $774.50 M(+3.3%) |
| Mar 1992 | - | $295.10 M(>+9900.0%) | $749.80 M(+3.8%) |
| Dec 1991 | $722.10 M(-9.9%) | $900.00 K(-99.7%) | $722.10 M(-17.6%) |
| Sept 1991 | - | $274.70 M(+53.4%) | $876.00 M(+3.7%) |
| June 1991 | - | $179.10 M(-33.0%) | $844.60 M(+3.4%) |
| Mar 1991 | - | $267.40 M(+72.7%) | $816.70 M(+1.9%) |
| Dec 1990 | $801.20 M(+17.6%) | $154.80 M(-36.4%) | $801.20 M(+9.2%) |
| Sept 1990 | - | $243.30 M(+60.9%) | $733.50 M(+3.6%) |
| June 1990 | - | $151.20 M(-40.0%) | $707.70 M(+2.2%) |
| Mar 1990 | - | $251.90 M(+189.2%) | $692.20 M(+1.6%) |
| Dec 1989 | $681.10 M(-13.9%) | $87.10 M(-60.0%) | $681.10 M(-7.4%) |
| Sept 1989 | - | $217.50 M(+60.3%) | $735.60 M(+0.1%) |
| June 1989 | - | $135.70 M(-43.6%) | $734.90 M(-9.5%) |
| Mar 1989 | - | $240.80 M(+70.1%) | $812.30 M(+2.7%) |
| Dec 1988 | $791.30 M(+14.6%) | $141.60 M(-34.7%) | $791.30 M(+0.6%) |
| Sept 1988 | - | $216.80 M(+1.7%) | $786.30 M(+4.1%) |
| June 1988 | - | $213.10 M(-3.0%) | $755.30 M(+5.2%) |
| Mar 1988 | - | $219.80 M(+60.9%) | $718.00 M(+4.0%) |
| Dec 1987 | $690.20 M(+4.6%) | $136.60 M(-26.5%) | $690.20 M(-3.1%) |
| Sept 1987 | - | $185.80 M(+5.7%) | $712.00 M(+1.3%) |
| June 1987 | - | $175.80 M(-8.4%) | $702.80 M(+2.9%) |
| Mar 1987 | - | $192.00 M(+21.2%) | $683.10 M(+3.5%) |
| Dec 1986 | $660.00 M(+13.9%) | $158.40 M(-10.3%) | $660.00 M(+3.0%) |
| Sept 1986 | - | $176.60 M(+13.1%) | $640.90 M(+3.4%) |
| June 1986 | - | $156.10 M(-7.6%) | $619.80 M(+3.1%) |
| Mar 1986 | - | $168.90 M(+21.2%) | $601.20 M(+3.7%) |
| Dec 1985 | $579.70 M(+14.1%) | $139.30 M(-10.4%) | $579.60 M(+1.8%) |
| Sept 1985 | - | $155.50 M(+13.1%) | $569.60 M(+4.2%) |
| June 1985 | - | $137.50 M(-6.7%) | $546.90 M(+3.7%) |
| Mar 1985 | - | $147.30 M(+13.9%) | $527.50 M(+3.9%) |
| Dec 1984 | $507.90 M | $129.30 M(-2.6%) | $507.90 M(+34.2%) |
| Sept 1984 | - | $132.80 M(+12.4%) | $378.60 M(+54.0%) |
| June 1984 | - | $118.10 M(-7.5%) | $245.80 M(+92.5%) |
| Mar 1984 | - | $127.70 M | $127.70 M |
FAQ
- What is Pfizer annual net profit?
- What is the all time high annual net income for Pfizer?
- What is Pfizer annual net income year-on-year change?
- What is Pfizer quarterly net profit?
- What is the all time high quarterly net income for Pfizer?
- What is Pfizer quarterly net income year-on-year change?
- What is Pfizer TTM net profit?
- What is the all time high TTM net income for Pfizer?
- What is Pfizer TTM net income year-on-year change?
What is Pfizer annual net profit?
The current annual net income of PFE is $2.12 B
What is the all time high annual net income for Pfizer?
Pfizer all-time high annual net profit is $31.37 B
What is Pfizer annual net income year-on-year change?
Over the past year, PFE annual net profit has changed by -$29.25 B (-93.25%)
What is Pfizer quarterly net profit?
The current quarterly net income of PFE is $4.46 B
What is the all time high quarterly net income for Pfizer?
Pfizer all-time high quarterly net profit is $14.10 B
What is Pfizer quarterly net income year-on-year change?
Over the past year, PFE quarterly net profit has changed by +$6.85 B (+287.45%)
What is Pfizer TTM net profit?
The current TTM net income of PFE is $4.25 B
What is the all time high TTM net income for Pfizer?
Pfizer all-time high TTM net profit is $31.37 B
What is Pfizer TTM net income year-on-year change?
Over the past year, PFE TTM net profit has changed by -$6.23 B (-59.44%)